Addressing Practical Challenges in HCV Management

In this on-demand multimedia module combining slides and audio from a live symposium presented at the 2016 annual meeting of the AASLD in Boston, Massachusetts, multidisciplinary expert faulty provide their perspectives on practical aspects of managing patients with HCV, including interpretation of current guidelines and payer policies, approaches to patient engagement in care, specialty pharmacy utilization and navigation of the insurance appeals process, and management of people who inject drugs.
Sherilyn C. Brinkley, MSN, CRNP
Jordan J. Feld, MD, MPH
Jason Grebely, BSc, PhD
Nancy Reau, MD, FAASLD, AGAF
Phoebe Sebhatu, PharmD, BCPS
Released: December 20, 2016

Information on this Educational Activity

Faculty

Sherilyn C. Brinkley, MSN, CRNP

Clinical Practitioner
Program Manager,
Viral Hepatitis Center
Division of Infectious Disease
Department of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland

Sherilyn C. Brinkley, MSN, CRNP, has disclosed that she has received funds for research support from AbbVie, Bristol-Myers Squibb, Gilead Sciences, and Merck and consulting fees from AbbVie and Merck.
Jordan J. Feld, MD, MPH

Associate Professor of Medicine
University of Toronto
Hepatologist
Toronto Centre for Liver Disease
Sandra Rotman Centre for Global Health
Toronto, Canada

Jordan J. Feld, MD, MPH, has disclosed that he has received funds for research support from Abbott, AbbVie, Gilead Sciences, Janssen, Merck, and Regulus and consulting fees from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, and Merck.
Jason Grebely, BSc, PhD

Associate Professor
The Kirby Institute, UNSW Australia
Sydney, Australia

Jason Grebely, BSc, PhD, has disclosed that he has received funds for research support from AbbVie, Cepheid, Gilead Sciences, and Merck; consulting fees from AbbVie, Gilead Sciences, and Merck; and fees for non-CME/CE services received directly from a commercial interest or their agents (eg, speaker bureaus) from AbbVie, Gilead Sciences, and Merck.
Nancy Reau, MD, FAASLD, AGAF

Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center
Chicago, Illinois

Nancy Reau, MD, FAASLD, AGAF, has disclosed that she has received funds for research support from AbbVie, Gilead Sciences, and Intercept and consulting fees from AbbVie, Bristol-Myers Squibb, Gilead Sciences, and Merck.
Phoebe Sebhatu, PharmD, BCPS

Clinical Pharmacy Specialist for Hepatology
Rush Specialty Pharmacy
Chicago, Illinois

Phoebe Sebhatu, PharmD, BCPS, has disclosed that she has received consulting fees from Bristol-Myers Squibb.

Program Medium

This program has been made available online.

Related Content

Latest data from a multicenter cohort study of HCC recurrence in patients receiving HCV DAA therapy following HCC CR at AASLD 2018 reported by Clinical Care Options

Released: November 12, 2018

Expert commentary from Dr. Mark Sulkowski on strategies to achieve HCV elimination in persons living with HIV

Mark S. Sulkowski, MD Released: November 8, 2018

Susanna Naggie, MD, MHS, on HCV and HIV coinfection FAQs and challenges. Guideline-based strategies, common DAA and ART drug interactions (DDIs).

Susanna Naggie, MD, MHS Released: September 13, 2018

Tool, education to avoid drug interactions, follow guidelines when choosing anti-HCV DAA and anti-HIV ART drugs for patients with HCV/HIV coinfection.

Susanna Naggie, MD, MHS Mark S. Sulkowski, MD Released: August 6, 2018

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?